128 related articles for article (PubMed ID: 29427046)
1. Hepatobiliary phase liver MR imaging findings after Oxaliplatin-based chemotherapy in cancer patients.
Ünal E; Karaosmanoğlu AD; Ozmen MN; Akata D; Karcaaltincaba M
Abdom Radiol (NY); 2018 Sep; 43(9):2321-2328. PubMed ID: 29427046
[TBL] [Abstract][Full Text] [Related]
2. Gd-EOB-DTPA-enhanced MR findings in chemotherapy-induced sinusoidal obstruction syndrome in colorectal liver metastases.
Ding Y; Rao SX; Wang WT; Chen CZ; Li RC; Zeng M
J Int Med Res; 2020 Jun; 48(6):300060520926031. PubMed ID: 32500783
[TBL] [Abstract][Full Text] [Related]
3. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
[TBL] [Abstract][Full Text] [Related]
4. Focal Nodular Hyperplasia After Treatment With Oxaliplatin: A Multiinstitutional Series of Cases Diagnosed at MRI.
Furlan A; Brancatelli G; Dioguardi Burgio M; Grazioli L; Lee JM; Murmura E; Lucidarme O; Strauss C; Rode A; Ronot M; Vilgrain V
AJR Am J Roentgenol; 2018 Apr; 210(4):775-779. PubMed ID: 29323545
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced focal hepatopathy in patients with gastrointestinal malignancy: gadoxetic acid--enhanced and diffusion-weighted MR imaging with clinical-pathologic correlation.
Han NY; Park BJ; Sung DJ; Kim MJ; Cho SB; Lee CH; Jang YJ; Kim SY; Kim DS; Um SH; Won NH; Yang KS
Radiology; 2014 May; 271(2):416-25. PubMed ID: 24475862
[TBL] [Abstract][Full Text] [Related]
6. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging.
Granata V; Catalano O; Fusco R; Tatangelo F; Rega D; Nasti G; Avallone A; Piccirillo M; Izzo F; Petrillo A
Abdom Imaging; 2015 Oct; 40(7):2364-71. PubMed ID: 26105523
[TBL] [Abstract][Full Text] [Related]
7. Correlation between Gd-EOB-DTPA-enhanced MR imaging findings and OATP1B3 expression in chemotherapy-associated sinusoidal obstruction syndrome.
Yoneda N; Matsui O; Ikeno H; Inoue D; Yoshida K; Kitao A; Kozaka K; Kobayashi S; Gabata T; Ikeda H; Nakamura K; Ohta T
Abdom Imaging; 2015 Oct; 40(8):3099-103. PubMed ID: 26187715
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin toxicity presenting as a liver nodule - case report.
Alexandrino H; Oliveira D; Cipriano MA; Ferreira L; Tralhão JG; Castro E Sousa F
BMC Cancer; 2015 Apr; 15():247. PubMed ID: 25886004
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin-induced liver injury mimicking metastatic tumor on images: a case report.
Uchino K; Fujisawa M; Watanabe T; Endo Y; Nobuhisa T; Matsumoto Y; Kai K; Sato S; Notohara K; Matsukawa A
Jpn J Clin Oncol; 2013 Oct; 43(10):1034-8. PubMed ID: 23958518
[TBL] [Abstract][Full Text] [Related]
10. The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia.
Overman MJ; Ferrarotto R; Raghav K; George B; Qiao W; Machado KK; Saltz LB; Mazard T; Vauthey JN; Hoff PM; Hobbs B; Loyer EM; Kopetz S
J Natl Cancer Inst; 2018 Aug; 110(8):888-894. PubMed ID: 29346573
[TBL] [Abstract][Full Text] [Related]
11. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
12. Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules.
Kim JW; Lee CH; Kim SB; Park BN; Park YS; Lee J; Park CM
J Magn Reson Imaging; 2017 Jun; 45(6):1599-1608. PubMed ID: 27726242
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis.
Stevenson HL; Prats MM; Sasatomi E
BMC Cancer; 2017 Jan; 17(1):35. PubMed ID: 28061766
[TBL] [Abstract][Full Text] [Related]
14. [Interstitial lung disease associated with combination chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin].
Park S; Jung JJ; Kim GB; Yoon HS; Ko SH; Ko JE; Lee YS
Korean J Gastroenterol; 2010 May; 55(5):340-3. PubMed ID: 20697195
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.
Zech CJ; Grazioli L; Breuer J; Reiser MF; Schoenberg SO
Invest Radiol; 2008 Jul; 43(7):504-11. PubMed ID: 18580333
[TBL] [Abstract][Full Text] [Related]
16. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.
Péporté AR; Sommer WH; Nikolaou K; Reiser MF; Zech CJ
Eur J Radiol; 2013 Mar; 82(3):e101-6. PubMed ID: 23159401
[TBL] [Abstract][Full Text] [Related]
17. Severe liver dysfunction and safe use of 5-fluorouracil leucovorin and oxaliplatin in one patient with metastatic colorectal carcinoma.
Tural D; Akar E; Öztürk MA; Yıldız Ö; Turna H; Serdengeçti S
J Cancer Res Ther; 2014; 10(3):745-8. PubMed ID: 25313774
[TBL] [Abstract][Full Text] [Related]
18. Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer.
Gagnadoux F; Roiron C; Carrie E; Monnier-Cholley L; Lebeau B
Am J Clin Oncol; 2002 Aug; 25(4):388-90. PubMed ID: 12151971
[TBL] [Abstract][Full Text] [Related]
19. Primovist, Eovist: what to expect?
Van Beers BE; Pastor CM; Hussain HK
J Hepatol; 2012 Aug; 57(2):421-9. PubMed ID: 22504332
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.
Culy CR; Clemett D; Wiseman LR
Drugs; 2000 Oct; 60(4):895-924. PubMed ID: 11085200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
